Literature DB >> 28000205

Early severe acute respiratory distress syndrome: What's going on? Part II: controlled vs. spontaneous ventilation?

Fabrice Petitjeans, Cyrille Pichot, Marco Ghignone, Luc Quintin1.   

Abstract

The second part of this overview on early severe ARDS delineates the pros and cons of the following: a) controlled mechanical ventilation (CMV: lowered oxygen consumption and perfect patient-to-ventilator synchrony), to be used during acute cardio-ventilatory distress in order to "buy time" and correct circulatory insufficiency and metabolic defects (acidosis, etc.); b) spontaneous ventilation (SV: improved venous return, lowered intrathoracic pressure, absence of muscle atrophy). Given a stabilized early severe ARDS, as soon as the overall clinical situation improves, spontaneous ventilation will be used with the following stringent conditionalities: upfront circulatory optimization, upright positioning, lowered VO2, lowered acidotic and hypercapnic drives, sedation without ventilatory depression and without lowered muscular tone, as well as high PEEP (titrated on transpulmonary pressure, or as a second best: "trial"-PEEP) with spontaneous ventilation + pressure support (or newer modes of ventilation). As these propositions require evidence-based demonstration, the reader is reminded that the accepted practice remains, in 2016, controlled mechanical ventilation, muscle relaxation and prone position.

Entities:  

Keywords:  ARDS; PEEP; Vt; acute hypoxic non-hypercapnic respiratory failure; acute respiratory distress syndrome; contr; driving pressure; low tidal volume; positive end-expiratory pressure; severe ARDS; tidal volume; transpulmonary pressure; ultra-low tidal volume

Mesh:

Substances:

Year:  2016        PMID: 28000205     DOI: 10.5603/AIT.2016.0057

Source DB:  PubMed          Journal:  Anaesthesiol Intensive Ther        ISSN: 1642-5758


  6 in total

Review 1.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

Review 2.  Building on the Shoulders of Giants: Is the use of Early Spontaneous Ventilation in the Setting of Severe Diffuse Acute Respiratory Distress Syndrome Actually Heretical?

Authors:  Fabrice Petitjeans; Cyrille Pichot; Marco Ghignone; Luc Quintin
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-09-01

3.  Avoiding, Not Managing, Drug Withdrawal Syndrome in the Setting of COVID-19 Acute Respiratory Distress Syndrome. Comment on Ego et al. How to Manage Withdrawal of Sedation and Analgesia in Mechanically Ventilated COVID-19 Patients? J. Clin. Med. 2021, 10, 4917.

Authors:  Fabrice Petitjeans; Marc de Kock; Marco Ghignone; Luc Quintin
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

4.  Clinical Practice: Should we Radically Alter our Sedation of Critical Care Patients, Especially Given the COVID-19 Pandemics?

Authors:  D Longrois; F Petitjeans; O Simonet; M de Kock; M Belliveau; C Pichot; Th Lieutaud; M Ghignone; L Quintin
Journal:  Rom J Anaesth Intensive Care       Date:  2021-01-04

5.  How should dexmedetomidine and clonidine be prescribed in the critical care setting?

Authors:  Dan Longrois; Fabrice Petitjeans; Olivier Simonet; Marc de Kock; Marc Belliveau; Cyrille Pichot; Thomas Lieutaud; Marco Ghignone; Luc Quintin
Journal:  Rev Bras Ter Intensiva       Date:  2022-01-24

Review 6.  A Centrally Acting Antihypertensive, Clonidine, Sedates Patients Presenting With Acute Respiratory Distress Syndrome Evoked by Severe Acute Respiratory Syndrome-Coronavirus 2.

Authors:  Fabrice Petitjeans; Jean-Yves Martinez; Marc Danguy des Déserts; Sandrine Leroy; Luc Quintin; Jacques Escarment
Journal:  Crit Care Med       Date:  2020-10       Impact factor: 9.296

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.